Skip to content

FDA Issues Warning Letters on STD “Treatments” Sold Online

March 6, 2008

From the FDA’s release: “The U.S. Food and Drug Administration today issued Warning Letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the Internet to U.S. consumers for the prevention and treatment of sexually transmitted diseases (STDs).”

The products are sold as Tetrasil, Genisil, Aviralex, OXi-MED, Imulux, Beta-mannan, Micronutrient, Qina, and SlicPlus, and FDA is advising consumers to stop using them immediately. They are not FDA approved, and the agency has raised concerns about inadequate directions and false or misleading claims.

It’s interesting to me that the FDA’s warning letters to the companies, in listing the promotional claims about the product, mentions the metatags of the websites – for example, “These claims are supplemented by the metatags that you use to bring consumers to your website. The metatags include ‘herpes treatment,’ ‘herpes genital treatment,’ and ‘herpes simplex treatment.'” In other words, luring people to the website with keywords unsupported by the medical evidence may also be a form of false/misleading claim.

Update: JUnkfood Science has commentary on this as well.

One Comment leave one →
  1. March 6, 2008 2:20 pm

    It is very important to consult with your doctor before taking or applying any unfamiliar medication. Treating a condition with the wrong medicine or therapy is not the way to cure your health concern – more to the point you can be putting your self in danger.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: